Dimitrios Lintzeris, DO
Family Medicine · Goldsboro, NCNPI 1710032271
Payments from drug & device makers
Across 183 payments — averaging $353.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$53K
- Integra Lifesciences Corporation$7K
- TEI Medical Inc.$4K
- Derma Sciences, Inc.$132
- Smith+Nephew$131
- Urgo Medical North America, LLC$58
- plus $197 from 8 others
What the payments were for
- Consulting fees$8,56713%
- Speaking & faculty fees$49,02976%
- Travel & lodging$4,9988%
- Food & beverage$2,1853%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 138 | $52,904 |
| Integra Lifesciences Corporation | 16 | $7,199 |
| TEI Medical Inc. | 5 | $4,157 |
| Derma Sciences, Inc. | 2 | $132 |
| Smith+Nephew | 7 | $131 |
| Urgo Medical North America, LLC | 3 | $58 |
| KCI USA, Inc. | 2 | $40 |
| Aroa Biosurgery Incorporated | 3 | $34 |
| Convatec Inc. | 2 | $33 |
| Reprise Biomedical, Inc. | 1 | $23 |
| OVIK Health, LLC | 1 | $21 |
| Solventum Corporation | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $15 |
| Next Science LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Apligraf$32,056
- Dermagraft$31,006
- Puraply/Affinity/NuTech$31,006
- PuraPly$9,672
- Puraply Antimicrobial$7,566
- IDRT$6,904
- BILAYER WOUND MATRIX (BWM)$6,776
- INTEGRA WOUND MATRIX (IWM)$6,776
- FLOWABLE$6,776
- PRIMATRIX$4,760
- TCC-EZ$4,417
- Affinity$2,050
- PURAPLY WOUND MATRIX$1,050
- NOVACHOR$1,050
- NuShield$1,050
- AMNIOEXCEL$260
- OMNIGRAFT$260
- MEDIHONEY$132
How this compares
$64,778 in reported general payments places this provider in the 95th percentile of 3,444 family medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $9,550 |
| OxycontinOxycodone Hcl | 21 | $6,275 |
| ErtapenemErtapenem Sodium | 12 | $5,359 |
| Daptomycin | 13 | $2,587 |
| Vancomycin Hcl | 14 | $1,349 |
| Ampicillin-SulbactamAmpicillin Sod/Sulbactam Sod | 16 | $1,217 |
| Linezolid | 13 | $1,003 |
| Doxycycline Hyclate | 36 | $981 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $662 |
| Sodium Chloride0.9 % Sodium Chloride | 45 | $543 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $535 |
| Gentamicin Sulfate | 12 | $461 |
| Metronidazole | 24 | $387 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $288 |
| Clindamycin Phosphate | 11 | $245 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Goldsboro
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
- Stephen JonesShelby$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.